Market Tracker

04/24 6:02pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

49.55
Delayed Data
As of Apr 24
 -0.53 / -1.06%
Today’s Change
22.12
Today|||52-Week Range
52.10
+56.41%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close50.08
Today’s open49.98
Day’s range49.55 - 50.53
Volume337,136
Average volume (3 months)641,027
Market cap$3.6B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+10.19%
Earnings growth (next 5 years)+29.31%
Revenue growth (last year)+16.53%
P/E ratio60.9
Price/Sales3.62
Price/Book3.97

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.31-0.71%
ACADACADIA Pharmaceutica...-0.54-1.39%
ASPXAuspex Pharmaceutica...-0.01-0.01%
CLVSClovis Oncology Inc+1.78+1.97%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)$0.17
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts